Followers | 27 |
Posts | 1014 |
Boards Moderated | 0 |
Alias Born | 08/19/2016 |
Thursday, February 09, 2017 8:43:24 AM
25 sites have been recruiting for the Prurisol phase 2b trial!!!
https://clinicaltrials.gov/ct2/show/study/NCT02949388?term=prurisol&rank=2&show_locs=Y#locn
Possible timeline regarding the Prurisol phase 2b trial
Last subject, #189, begin treatment by or before mid February 2017.
All 189 patients will have completed at least 6 weeks of treatment by or before the beginning of April 2017
The interim 6 week data should be sufficient to draw EXTREME INTEREST from several BIG PHARMACEUTICALS
Interim 6 week data for all 189 subjects available by May 2017.
By June 2017 all 189 subjects will have completed at least 12 weeks of treatment.
By mid July 2017 final data for all 189 subjects will be available.
Prurisol alone is worth at least $10 Billion!!!
In 5 to 6 months BIG PHARMA will know that Prurisol is worth at least $10 Billion!!!
This is what I expect from the interim results for subjects taking 150 mg BID or 200 mg BID at just 6 weeks just half way through the phase 2b trial.
First, I expect that the trial will start with 20% of the subjects to have severe psoriasis and 80% to have moderate psoriasis.
For the interim results at just 6 weeks I expect 4% of subjects to be severe (IGA 4), 29% of subjects to be moderate (IGA 3), 38% of subjects to be mild (IGA 2), 29% of the subjects to be almost clear (IGA 1) or clear (IGA 0).
I expect 29% of subjects taking 150 mg BID or 200 mg BID to be at PASI 75 at just 6 weeks just half way through the phase 2b trial.
I estimate that Prurisol at 300 mg per day bid will achieve a PASI 75 responses of 82.5% at 12 weeks
I estimate that Prurisol at 400 mg per day bid will achieve a PASI 75 responses of 100% at 12 weeks
cellceutix.com/wp-content/uploads/2014/06/Prurisol-Presentation-for-Med-Derm-RD-Workshop_19Sep2016-u.pdf
Good luck and GOD bless,
RUNNINGGIRL2016
TIC TOC KABOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOOM!!!
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM
Bemax Inc. Positions to Capitalize on Industry Growth with New Improved Quality of Mother's Touch® Disposable Diapers • BMXC • Jun 24, 2024 8:00 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM